A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...

DelveInsight's, “CRISPR Therapies Pipeline Insight, 2025,” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the ...

Biochemist Jennifer Doudna received the inaugural Kimberly Prize in Biochemistry and Molecular Genetics at the Robert H. Lurie Medical Research Center on Tuesday. The prize will be awarded annually to ...

A popular gene-editing technique may unintentionally delete and rearrange DNA bases, according to a new study published in Nature Biotechnology. The study involves the use of CRISPR-Cas9, a system ...

CRISPR Therapeutics shares jump after early zugo-cel study data show sustained B-cell depletion and early efficacy across autoimmune and cancer studies.

The healthcare industry, on the other hand, has been a bit of a laggard. Could they keep the momentum going in 2026? Let's ...